Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

Chest

Volumn 114, Issue 4, 1998, Pages 1105-1111

  Gupta, Naresh ^a,b   Gill, Harmindar ^a   Graeber, Geoffrey ^a   Bishop, Harry ^a   Hurst, Janis ^a   Stephens, Timothy ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Metabolism; PET; Pulmonary

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MEDIASTINUM TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0031731832     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.4.1105     Document Type: Article

References (18)

1. Gupta NC, Frick MP. Clinical applications of positron emission tomography in cancer. Ca Cancer J Clin 1993; 43:235-254
2. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[K-18]-fluoro-2-deoxy-glucose. Radiology 1992; 188:442-444
3. Lowe VJ, Hoffman JM, Delong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776
4. Monakhav NK, Neistadt EL, Showlowskil MM. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978; 67:27-34
5. Warburg OH. The metabolism of tumors. New York, NY: Richard R Smith, 1931; 29-107
6. Weber G. Enzymology of cancer cells (first of two parts). N Engl J Med 1937; 296:486-492
7. Gupta N, Berger JD, Chandramouli B. Normal variability in the mediastinal FDG activity on FDG PET studies of lung tumors. Radiology 1994; 193:193(P)
8. Patlak CS, Blasberg RG, Frenstermacher ID. Graphical evaluation of blood-to-brain transfer constant from multiple-time uptake data. J Cereb Blood Flow Metab 1981; 5:163-178
9. Weinstock S. Changing perceptions of carbohydrate metabolism in tumor. In: Armott MS, Van Eys SJ, Waby JM, et al, eds. Molecular interrelations of nutrition and cancer. New York, NY: Raven, 1981; 167-181
10. Yamamato T, Scino Y, Fukumato H, et al. Over expression of facilitative glucose transporters genes in human cancer. Biochem Biophys Res Commun 1990; 170:223-230
11. Nolop KB, Rhodes CG, Grudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682-2689
12. Higashi K, Clavo AC, Wahl RC. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993; 34:414-419
13. Flier JS, Mueckler MM, Usher P, et al. Elevated levels of glucose transporter and transporter messenger RNA are induced by rats or Src oncogenes. Science 1987; 235:1492-1495
14. 18F]FDG). Gynecol Oncol 1993; 51:197-204
15. 18F-fluorodeoxyglucose for differential diagnosis of lung tumor. J Nucl Med 1989; 30:788-789
16. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:993-998
17. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490
18. Fujiwara T, Matsuzama T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-methionine uptake with positron emission tomography. J Nucl Med 1989; 30:33-37